BIONIK LABORATORIES CORP. (BNKL) financial statements (2021 and earlier)

Company profile

Business Address 483 BAY STREET
TORONTO, ON M5G2C9
State of Incorp. DE
Fiscal Year End March 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1201170
Cash and cash equivalents1201170
Receivables012000 
Inventory, net of allowances, customer advances and progress billings11000  
Inventory11000  
Prepaid expense200000 
Other undisclosed current assets 21000 
Total current assets:4641170
Noncurrent Assets
Property, plant and equipment000000 
Intangible assets, net (including goodwill)513272727  
Goodwill411222222  
Intangible assets, net (excluding goodwill)11455  
Total noncurrent assets:5132727280 
TOTAL ASSETS:91931292970
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3332200
Accounts payable111110 
Accrued liabilities222210 
Other undisclosed accounts payable and accrued liabilities      0
Deferred revenue01
Debt42 01  
Deferred revenue and credits00  
Customer advances and deposits00  
Other undisclosed current liabilities0 063 0
Total current liabilities:7538600
Noncurrent Liabilities
Liabilities, other than long-term debt0      
Deferred revenue0 
Total noncurrent liabilities:0      
Other undisclosed liabilities     6 
Total liabilities:8538660
Stockholders' equity
Stockholders' equity attributable to parent, including:1132720231(0)
Common stock000000 
Additional paid in capital858574563911(0)
Accumulated other comprehensive income000000 
Accumulated deficit(84)(71)(46)(36)(16)(11)(0)
Other undisclosed stockholders' equity attributable to parent     00
Total stockholders' equity:1132720231(0)
TOTAL LIABILITIES AND EQUITY:91931292970

Income statement (P&L) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
12/31/2015
12/31/2014
Revenues0001100
Revenue, net11  
Other operating income000  0 
Cost of revenue(0)(1)(2)(0)(0) (0)
Cost of goods and services sold(0)(1)(2)(0)(0)  
Other undisclosed gross profit123    
Gross profit:112100(0)
Operating expenses(16)(12)(11)(10)(9)(6)(0)
Operating loss:(15)(11)(9)(10)(9)(6)(0)
Nonoperating income (expense)(14)(14)(1)(5)91 
Investment income, nonoperating    40 
Other nonoperating income (expense)(14)(14)(1)(5)50 
Interest and debt expense(0) 0(1)(0)(0) 
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  (0)1(4)(1) 
Loss before gain (loss) on sale of properties:(29)(25)(11)(15)(4)(6)(0)
Other undisclosed net income3750     
Net income (loss):825(11)(15)(4)(6)(0)
Other undisclosed net income attributable to parent13 21    
Net income (loss) available to common stockholders, diluted:212511(15)(4)(6)(0)

Comprehensive Income ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
12/31/2015
12/31/2014
Net income (loss):825(11)(15)(4)(6)(0)
Comprehensive income (loss):825(11)(15)(4)(6)(0)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(37)(50)   0 
Comprehensive loss, net of tax, attributable to parent:(29)(25)(11)(15)(4)(6)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: